Evidence map›Paper›PMID 37755795›Full record

ArticleToxics2023

Datasets Construction and Development of QSAR Models for Predicting Micronucleus In Vitro and In Vivo Assay Outcomes.

Lusine Khondkaryan, Ani Tevosyan, Hayk Navasardyan, Hrant Khachatrian, Gohar Tadevosyan, Lilit Apresyan, Gayane Chilingaryan, Zaven Navoyan, Helga Stopper, Nelly Babayan

Abstract read
In one paragraph

Article in Toxics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lusine KhondkaryanInstitute of Molecular Biology, NAS RA, Yerevan 0014, Armenia.
Ani TevosyanToxometris.ai, Yerevan 0009, Armenia.
Hayk NavasardyanToxometris.ai, Yerevan 0009, Armenia.
Hrant KhachatrianYerevaNN, Yerevan 0025, Armenia.
Gohar TadevosyanInstitute of Molecular Biology, NAS RA, Yerevan 0014, Armenia.
Lilit ApresyanInstitute of Molecular Biology, NAS RA, Yerevan 0014, Armenia.
Gayane ChilingaryanYerevaNN, Yerevan 0025, Armenia.
Zaven NavoyanToxometris.ai, Yerevan 0009, Armenia.
Helga StopperInstitute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany.ORCID 0000-0003-4168-8211
Nelly BabayanInstitute of Molecular Biology, NAS RA, Yerevan 0014, Armenia.ORCID 0000-0001-9205-7693

Funding

RA MES State Committee of Science № 20TTCG-1F004
6 · The paper itself

Abstract

In silico (quantitative) structure-activity relationship modeling is an approach that provides a fast and cost-effective alternative to assess the genotoxic potential of chemicals. However, one of the limiting factors for model development is the availability of consolidated experimental datasets. In the present study, we collected experimental data on micronuclei in vitro and in vivo, utilizing databases and conducting a PubMed search, aided by text mining using the BioBERT large language model. Chemotype enrichment analysis on the updated datasets was performed to identify enriched substructures. Additionally, chemotypes common for both endpoints were found. Five machine learning models in combination with molecular descriptors, twelve fingerprints and two data balancing techniques were applied to construct individual models. The best-performing individual models were selected for the ensemble construction. The curated final dataset consists of 981 chemicals for micronuclei in vitro and 1309 for mouse micronuclei in vivo, respectively. Out of 18 chemotypes enriched in micronuclei in vitro, only 7 were found to be relevant for in vivo prediction. The ensemble model exhibited high accuracy and sensitivity when applied to an external test set of in vitro data. A good balanced predictive performance was also achieved for the micronucleus in vivo endpoint.

Indexed as

chemotypes analysisensemblein vitroin vivomicronucleusprediction

Identifiers

PMID37755795
PMCPMC10537630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.